Homotopic Connectivity as a Biomarker of Alzheimer's Disease
ISEF · 2024 Translational Medical Science Third Award
Overview
Cognitive impairment is a common, non-specific early presenting symptom in neurodegenerative diseases, including Alzheimer's disease (AD). A biomarker differentiating AD-related cognitive impairment would be advantageous. In AD, beta-amyloid plaques and tau tangles characteristically aggregate in the brain's temporal lobe, disrupting normal cognitive functioning such as memory. Homotopic connectivity, as measured by resting-state functional Magnetic Resonance Imaging (rs-fMRI), quantifies how the measured blood oxygen level-dependent (BOLD) signal, indicative of spontaneous neural activity, is similar in mirrored left-right brain hemisphere regions. Using data from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database, this project investigated homotopic connectivity in a population with and without pathological beta-amyloid burden to determine if AD was associated with a disruption in the temporal lobe's homotopic connectivity. Demographics, cognitive data, MRI scans, amyloid status, and tau burden were obtained from the ADNI database. rs-fMRI connectivity for 50 homotopic regions was quantified using the CONN toolbox and custom Matlab scripts. All statistical analyses were performed in SPSS. Study results indicated that homotopic connectivity is a robust connectivity measure in a healthy control population (mean r > 0.7). Compared to amyloid-negative controls, homotopic connectivity was significantly decreased within temporal lobe regions for the amyloid-positive groups. Homotopic connectivity correlated to cognitive function and inversely to tau burden. Findings from this work support homotopic connectivity as a potential neuroimaging biomarker for Alzheimer's disease and, most notably, a sensitive biomarker even before the manifestations of symptoms.
Awards (1)
- Third Award of $1,000 $1,000
Competition history
- ISEF 2024
Resources
Related projects
ISEF · 2018
EEG Coherence as a Marker for Alzheimer’s Dementia
ISEF · 2017
Evaluating Autism Connectivity Abnormalities through Functional Fingerprinting
ISEF · 2022
Developing an Algorithm To Analyze Structural Characteristics of Alzheimer's Disease in Different Stages of Mild Cognitive Impairment and Validate White Matter Atrophy as an Early Predictor of Mild Cognitive Impairment (A Novel Second Year Study)
ISEF · 2020
Spatiotemporal Pattern of Neuropathology in the Olfactory System as a Biomarker for Onset of Alzheimer’s Disease in a Rat Model
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair